Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push
Update: 2025-10-29
Description
Eli Lilly is investing over $1.2 billion to expand its Carolina, Puerto Rico manufacturing facility, focusing on producing its new weight-loss pill, orforglipron, and other treatments for heart disease, diabetes, cancer, and immune disorders. This expansion aims to boost domestic production and reduce reliance on imports, creating around 100 new jobs and potentially needing up to 1000 workers during construction. The project is part of Lilly's broader strategy to spend $50 billion on U.S. manufacturing expansions, with two additional sites planned for Texas and Virginia.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
